Anatolii Zagorodnii

Contributing Author in
Bioeconomy & Society

Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.

Articles from Anatolii

UK Rolls Out National Strategy to Build Europe’s Life Sciences Powerhouse by 2030

The UK government has released a new Industrial Strategy white paper outlining plans to strengthen the country’s life sciences sector. Building on the previous green paper and industry consultations, the document proposes targeted investment, regulatory changes, and measures to support talent development and data infrastructure. It sets long-term goals to expand the UK’s role in the global life sciences economy, with a stated aim of becoming Europe’s leading hub by 2030 and ranking third globally by 2035.

The Stage Is Set: London Biotechnology Show 2025

The inaugural London Biotechnology Show (LBS 2024) took place on 8–9 May 2024 at Olympia West, London, and culminated in an insightful discussion of emerging disruptive technologies such as AI in drug discovery, scalable cell and gene therapies and many more, ultimately attracting over 3,000 attendees and 1,500 companies across the biopharma sector.

A Call to Improve the UK Life Sciences Sector, Home to Over 6,800 Companies

In October 2024, the UK Government released an Industrial Strategy green paper outlining a 10-year plan for the sustainable economic growth of the country and initiating the dialogue with the public and industry representatives ahead of the white paper release, scheduled for June 2025.